StockNews.com initiated coverage on shares of Lipocine (NASDAQ:LPCN – Free Report) in a research report released on Saturday morning. The brokerage issued a sell rating on the specialty pharmaceutical company’s stock. Lipocine Stock Performance LPCN opened at $4.80 on Friday. Lipocine has a fifty-two week low of $2.31 and a fifty-two week high of $7.15. […]
StockNews.com assumed coverage on shares of Lipocine (NASDAQ:LPCN – Free Report) in a report published on Tuesday. The firm issued a sell rating on the specialty pharmaceutical company’s stock. Lipocine Stock Performance Shares of LPCN stock opened at $5.20 on Tuesday. The stock’s 50 day simple moving average is $4.04 and its 200 day simple […]
StockNews.com started coverage on shares of Lipocine (NASDAQ:LPCN – Free Report) in a research report sent to investors on Thursday morning. The firm issued a sell rating on the specialty pharmaceutical company’s stock. Lipocine Price Performance Shares of Lipocine stock opened at $4.01 on Thursday. Lipocine has a fifty-two week low of $2.31 and a […]
StockNews.com assumed coverage on shares of Lipocine (NASDAQ:LPCN – Free Report) in a report published on Tuesday. The firm issued a sell rating on the specialty pharmaceutical company’s stock. Lipocine Trading Up 2.1 % Shares of NASDAQ:LPCN opened at $3.98 on Tuesday. The stock has a fifty day simple moving average of $3.07 and a […]
StockNews.com began coverage on shares of Lipocine (NASDAQ:LPCN – Free Report) in a research note issued to investors on Monday. The brokerage issued a sell rating on the specialty pharmaceutical company’s stock. Lipocine Stock Performance Shares of NASDAQ:LPCN opened at $3.83 on Monday. Lipocine has a fifty-two week low of $2.31 and a fifty-two week […]